<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Basu SS</submitter><funding>NIBIB NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>4987-4991</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6196362</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>90(8)</volume><pubmed_abstract>Conventional metabolomic methods include extensive sample preparation steps and long analytical run times, increasing the likelihood of processing artifacts and limiting high throughput applications. We present here in vitro liquid extraction surface analysis mass spectrometry (ivLESA-MS), a variation on LESA-MS, performed directly on adherent cells grown in 96-well cell culture plates. To accomplish this, culture medium was aspirated immediately prior to analysis, and metabolites were extracted using LESA from the cell monolayer surface, followed by nano-electrospray ionization and MS analysis in negative ion mode. We applied this platform to characterize and compare lipidomic profiles of multiple breast cancer cell lines growing in culture (MCF-7, ZR-75-1, MDA-MB-453, and MDA-MB-231) and revealed distinct and reproducible lipidomic signatures between the cell lines. Additionally, we demonstrated time-dependent processing artifacts, underscoring the importance of immediate analysis. ivLESA-MS represents a rapid in vitro metabolomic method, which precludes the need for quenching, cell harvesting, sample preparation, and chromatography, significantly shortening preparation and analysis time while minimizing processing artifacts. This method could be further adapted to test drugs in vitro in a high throughput manner.</pubmed_abstract><journal>Analytical chemistry</journal><pubmed_title>In Vitro Liquid Extraction Surface Analysis Mass Spectrometry (ivLESA-MS) for Direct Metabolic Analysis of Adherent Cells in Culture.</pubmed_title><pmcid>PMC6196362</pmcid><funding_grant_id>T32 HL007627</funding_grant_id><funding_grant_id>P41 EB015898</funding_grant_id><funding_grant_id>R01 CA201469</funding_grant_id><funding_grant_id>R25 CA089017</funding_grant_id><funding_grant_id>U54 CA210180</funding_grant_id><pubmed_authors>Basu SS</pubmed_authors><pubmed_authors>Agar NYR</pubmed_authors><pubmed_authors>Regan MS</pubmed_authors><pubmed_authors>Dillon DA</pubmed_authors><pubmed_authors>Randall EC</pubmed_authors><pubmed_authors>Lopez BGC</pubmed_authors><pubmed_authors>Clark AR</pubmed_authors><pubmed_authors>Schmitt ND</pubmed_authors><pubmed_authors>Agar JN</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Vitro Liquid Extraction Surface Analysis Mass Spectrometry (ivLESA-MS) for Direct Metabolic Analysis of Adherent Cells in Culture.</name><description>Conventional metabolomic methods include extensive sample preparation steps and long analytical run times, increasing the likelihood of processing artifacts and limiting high throughput applications. We present here in vitro liquid extraction surface analysis mass spectrometry (ivLESA-MS), a variation on LESA-MS, performed directly on adherent cells grown in 96-well cell culture plates. To accomplish this, culture medium was aspirated immediately prior to analysis, and metabolites were extracted using LESA from the cell monolayer surface, followed by nano-electrospray ionization and MS analysis in negative ion mode. We applied this platform to characterize and compare lipidomic profiles of multiple breast cancer cell lines growing in culture (MCF-7, ZR-75-1, MDA-MB-453, and MDA-MB-231) and revealed distinct and reproducible lipidomic signatures between the cell lines. Additionally, we demonstrated time-dependent processing artifacts, underscoring the importance of immediate analysis. ivLESA-MS represents a rapid in vitro metabolomic method, which precludes the need for quenching, cell harvesting, sample preparation, and chromatography, significantly shortening preparation and analysis time while minimizing processing artifacts. This method could be further adapted to test drugs in vitro in a high throughput manner.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2020-10-29T09:52:20Z</modification><creation>2019-03-27T00:03:19Z</creation></dates><accession>S-EPMC6196362</accession><cross_references><pubmed>29608279</pubmed><doi>10.1021/acs.analchem.8b00530</doi></cross_references></HashMap>